Recent Updates
Recently added Catalysts
RIGL Positive Sentiment

Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update

Tuesday, July 29, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rigel Pharmaceuticals, Inc. announced that it will report its second quarter 2025 financial results on August 5, 2025. The announcement includes a live conference call and webcast scheduled for the same day, allowing participants to engage directly with senior management. The company is committed to informing stakeholders about its financial performance and current business updates. The webcast will also be archived for later access.
Price reaction · baseline $19.99 (2025-07-28 close) · hit after-hours · clean, no other RIGL news in the window
day 0 close · peak
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcing financial results demonstrates transparency.
  • Live conference call provides direct engagement with investors.
  • Potential insight into future business strategies and developments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+9%
120-day peak, hindsight
Typical move
12.1%
average across 2 past catalysts
Lead asset
Fostamatinib
Phase 2 · Acute Respiratory Distress Syndrome

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., July 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2025 financial results after market close on Tuesday, August 5, 2025. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
Email: [email protected]

Frequently Asked Questions

When will Rigel Pharmaceuticals report its Q2 2025 financial results?

Rigel will report its Q2 2025 financial results on August 5, 2025.

What time is the Rigel conference call scheduled?

The live conference call is at 4:30 p.m. Eastern Time.

How can I access the Rigel conference call?

Access the call by dialing 877-407-3088 domestically or 201-389-0927 internationally.

Where can I find the webcast of Rigel’s conference call?

The webcast is available in the Investor Relations section of Rigel's website.

How long will the Rigel webcast be available for replay?

The webcast will be archived and available for replay for 90 days.

ShareAdd on Google
Tags: RIGL Viatris Investor Conferences Healthcare Q2 2025 financial results webcast investor relations
Last updated: Jul 29, 2025

Biotech snapshot

Cash runway
$95M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FostamatinibPhase 2
Acute Respiratory Distress Syndrome →

Catalyst track record

+9%
best trade around RIGL's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for RIGL.

See every catalyst's timing & PoA →